Prescribing pattern of dipeptidyl peptidase 4 inhibitors and level of HBA1C target achievements among outpatients with type 2 diabetes mellitus in a Malaysian university teaching hospital

• Main Authors: Elnaem, Mohamed Hassan Abdelaziz, Shamsuri, Mohamad Hafiz Hakeem, Mohamad Aziz, Nur Athirah, Alias, Nurul Iman, Hafizi, Rauha Farhana, Latif, Nur Faezah, Rashid, Arina Norhazwani, Mohamad Jalil, Mohd Faris Aiman, Wei Ying, Mery Hu
• Format: Article
• Language: English; English
• Published: Walter de Gruyter 2020
• Subjects: RM Therapeutics. Pharmacology
• Online Access: http://irep.iium.edu.my/87530/7/87530_Prescribing%20pattern%20of%20dipeptidyl%20peptidase.pdf; http://irep.iium.edu.my/87530/13/87530_Prescribing%20pattern%20of%20dipeptidyl%20peptidase%204%20inhibitors_Scopus.pdf; http://irep.iium.edu.my/87530/; http://www.rjdnmd.org/index.php/RJDNMD/article/view/754

Background and aims: Oral antidiabetic drugs, including Dipeptidyl Peptidase 4 Inhibitors (DPP4i), are the mainstay for therapeutic management of type 2 diabetes mellitus (T2DM). We aimed to describe the prescribing pattern of DPP4i agents and to assess the achievement of the target HbA1c levels am...